CELLSIGHT
Live / Allowed — Publication / registration review complete (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99426428
- Mark type
- Stylized text
- Filed
- 03 Oct 2025
- Published for opposition
- 21 Apr 2026
- Attorney of record
- Jennifer Whitelaw
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable webinars in the field of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Downloadable electronic publications in the nature of newsletters and abstracts in the field of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Downloadable computer software for scientific analysis of genetic sequences; Downloadable computer software for accessing, reading, and tracking information in the field of medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of enhancing the analysis of research, and managing the review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis on a blockchain; Downloadable computer software for medical diagnosis, testing, and analysis of medical test results; Downloadable medical software for medical diagnosis, testing, and analysis of medical test results
- Class 042 — Scientific and technological services: Medical and scientific research information in the field of human disease and human medical conditions; Scientific research; Scientific research for medical purposes in the field of human disease and human medical conditions; Medical research in the field of infectious diseases; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Medical research laboratory services in the field of oncology; Providing information on clinical studies via an interactive website; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Medical and scientific research consulting services for others in the field of design, planning, and implementation project management of scientific testing and research and clinical scientific testing; Developing customized web pages and other data feed formats featuring user-defined information in the field of scientific testing and research, medical research, and clinical scientific testing; Providing temporary use of non-downloadable cloud-based software for the management of scientific testing and research, medical research, and clinical scientific testing; Providing online non-downloadable computer networking software; Providing on-line non-downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis using blockchain technology; Software as a service (SAAS) services in the nature of hosting cloud-based software of others; Software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; Genetic mapping for scientific purposes; DNA sequencing technology research; Medical research services in the field of cancer; Research in the field of cytogenetics; Laboratory services for the production of chemotherapy drugs in the nature of clinical study and testing of cells, cell analysis and cell preservation; Research and development in the field of medical scientific research, particularly in relation to gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; Providing scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer
- Class 044 — Medical, beauty and agricultural services: Medical information; Medical diagnostic services; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Providing medical information in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; Medical information services provided via the Internet; Providing medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results
Owner
- Cancer Cell Diagnostics, Inc., Naples, FL, US
Prosecution history
- 25 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 25 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 25 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 24 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION WRITTEN
- 23 Feb 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Oct 2025 — NEW APPLICATION ENTERED